Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Taps Dotmatics Platform for Neuroscience Drug Discovery

Premium

Dotmatics said this week that AstraZeneca's Neuroscience Innovative Medicines Unit has selected its platform to manage research data associated with its collaborative drug discovery efforts.

Dotmatics platform will provide a single point of access to all data and functions for AstraZeneca and its partners, the company said. These users will have access to compound registration and tracking tools, biological screening, DMPK analysis, as well as a fully integrated chemistry and biology electronic laboratory notebook and project management capabilities.

The financial details of the agreement were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.